The collaboration between Intelligent Bio Solutions (INBS) and Syrma Johari to scale up production of the intelligent fingerprint drug screening reader is a textbook example of how strategic partnerships can…
Curasight’s initiation of the Phase I clinical trial for its uTREAT diagnostic platform targeting high-grade gliomas marks a noteworthy milestone in neuro-oncology diagnostics. However, as healthcare marketing professionals, we must…
Peter Collins stepping in as CEO of CellBxHealth and immediately shifting away from the entrenched one-stop-shop research model signals a crucial, if overdue, recalibration. The original model, while ambitious, often…
ZOLL’s recent unveiling of the next-generation LifeVest wearable cardioverter defibrillator (WCD) in the US is positioned as a forward leap in cardiac care technology. However, healthcare marketing professionals should critically…